Hydroxyurea in Sickle Cell Disease and Invasive Bacterial Infections: A Case-Control Study
- PMID: 38970408
- DOI: 10.1093/jpids/piae071
Hydroxyurea in Sickle Cell Disease and Invasive Bacterial Infections: A Case-Control Study
Abstract
Hydroxyurea decreases painful events among children with sickle cell disease (SCD) but could increase the risk of infections in treated patients through leucopenia. We performed a case-control study, comparing hydroxyurea treatment for SCD in cases with an invasive bacterial infection and in controls without infection. No difference was found.
Keywords: early treatment; hydroxyurea; invasive bacterial infections; sickle cell disease; spleen function.
© The Author(s) 2024. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
